Crystal E Tan1, Stanton A Glantz. 1. Center for Tobacco Control Research and Education, University of California, San Francisco, 520 Parnassus Ave, #366, San Francisco, CA 94143, USA.
Abstract
BACKGROUND: Secondhand smoke causes cardiovascular and respiratory disease. Smoke-free legislation is associated with a lower risk of hospitalization and death from these diseases. METHODS AND RESULTS: Random-effects meta-analysis was conducted by law comprehensiveness to determine the relationship between smoke-free legislation and hospital admission or death from cardiac, cerebrovascular, and respiratory diseases. Studies were identified by using a systematic search for studies published before November 30, 2011 with the use of the Science Citation Index, Google Scholar, PubMed, and Embase and references in identified articles. Change in hospital admissions (or deaths) in the presence of a smoke-free law, duration of follow-up, and law comprehensiveness (workplaces only; workplaces and restaurants; or workplaces, restaurants, and bars) were recorded. Forty-five studies of 33 smoke-free laws with median follow-up of 24 months (range, 2-57 months) were included. Comprehensive smoke-free legislation was associated with significantly lower rates of hospital admissions (or deaths) for all 4 diagnostic groups: coronary events (relative risk, 0.848; 95% confidence interval 0.816-0.881), other heart disease (relative risk, 0.610; 95% confidence interval, 0.440-0.847), cerebrovascular accidents (relative risk, 0.840; 95% confidence interval, 0.753-0.936), and respiratory disease (relative risk, 0.760; 95% confidence interval, 0.682-0.846). The difference in risk following comprehensive smoke-free laws does not change with longer follow-up. More comprehensive laws were associated with larger changes in risk. CONCLUSIONS: Smoke-free legislation was associated with a lower risk of smoking-related cardiac, cerebrovascular, and respiratory diseases, with more comprehensive laws associated with greater changes in risk.
BACKGROUND: Secondhand smoke causes cardiovascular and respiratory disease. Smoke-free legislation is associated with a lower risk of hospitalization and death from these diseases. METHODS AND RESULTS: Random-effects meta-analysis was conducted by law comprehensiveness to determine the relationship between smoke-free legislation and hospital admission or death from cardiac, cerebrovascular, and respiratory diseases. Studies were identified by using a systematic search for studies published before November 30, 2011 with the use of the Science Citation Index, Google Scholar, PubMed, and Embase and references in identified articles. Change in hospital admissions (or deaths) in the presence of a smoke-free law, duration of follow-up, and law comprehensiveness (workplaces only; workplaces and restaurants; or workplaces, restaurants, and bars) were recorded. Forty-five studies of 33 smoke-free laws with median follow-up of 24 months (range, 2-57 months) were included. Comprehensive smoke-free legislation was associated with significantly lower rates of hospital admissions (or deaths) for all 4 diagnostic groups: coronary events (relative risk, 0.848; 95% confidence interval 0.816-0.881), other heart disease (relative risk, 0.610; 95% confidence interval, 0.440-0.847), cerebrovascular accidents (relative risk, 0.840; 95% confidence interval, 0.753-0.936), and respiratory disease (relative risk, 0.760; 95% confidence interval, 0.682-0.846). The difference in risk following comprehensive smoke-free laws does not change with longer follow-up. More comprehensive laws were associated with larger changes in risk. CONCLUSIONS:Smoke-free legislation was associated with a lower risk of smoking-related cardiac, cerebrovascular, and respiratory diseases, with more comprehensive laws associated with greater changes in risk.
Authors: Mary Kay Rayens; Patricia V Burkhart; Mei Zhang; Seongjik Lee; Debra K Moser; David Mannino; Ellen J Hahn Journal: J Allergy Clin Immunol Date: 2008-08-09 Impact factor: 10.793
Authors: S Vasselli; P Papini; D Gaelone; L Spizzichino; E De Campora; R Gnavi; C Saitto; N Binkin; G Laurendi Journal: Minerva Cardioangiol Date: 2008-04 Impact factor: 1.347
Authors: John Moraros; Yelena Bird; Shande Chen; Robert Buckingham; Richard S Meltzer; Surasri Prapasiri; Luis H Solis Journal: Int J Environ Res Public Health Date: 2010-12-02 Impact factor: 3.390
Authors: Kranthi Pinnamaneni; Richard E Sievers; Rikki Sharma; Amanda M Selchau; Gustavo Gutierrez; Eric J Nordsieck; Robert Su; Songtao An; Qiumei Chen; Xiaoyin Wang; Ronak Derakhshandeh; Kirstin Aschbacher; Christian Heiss; Stanton A Glantz; Suzaynn F Schick; Matthew L Springer Journal: Nicotine Tob Res Date: 2013-12-03 Impact factor: 4.244
Authors: Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh Journal: Circulation Date: 2016-11-13 Impact factor: 29.690
Authors: Mary Kate Mohlman; Dina N K Boulos; Maged El Setouhy; Ghada Radwan; Kepher Makambi; Irene Jillson; Christopher A Loffredo Journal: Nicotine Tob Res Date: 2013-01-17 Impact factor: 4.244
Authors: Mariaelena Gonzalez; Ashley Sanders-Jackson; Anna V Song; Kai-wen Cheng; Stanton A Glantz Journal: Am J Public Health Date: 2013-03-14 Impact factor: 9.308